This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: "Monogram Biosciences" – news · newspapers · books · scholar · JSTOR (August 2022) (Learn how and when to remove this message)
This article includes a list of general references, but it lacks sufficient corresponding inline citations. Please help to improve this article by introducing more precise citations. (May 2010) (Learn how and when to remove this message)
Monogram Biosciences, Inc.
Company typeSubsidiary
IndustryBiotechnology
HeadquartersSouth San Francisco, California
ProductsPhenoSense, PhenoSense GT, Trofile, GeneSeq, VeraTag, HERmark
Number of employees
379 (2008)
ParentLabCorp
Websitehttp://www.monogrambio.com/

Monogram Biosciences, Inc. (formerly ViroLogic Inc.) is an international biotechnology laboratory located in South San Francisco, California, USA and is a subsidiary of LabCorp. Monogram develops and markets assays to help guide and improve the treatment of infectious diseases (including HIV and Hepatitis) and cancer.

Virologic was founded in 1996 by Daniel Capon, Ph.D., Martin Goldstein and Robert S. Capon. The company went public (NASDAQ: VLGC) in 2000.[1]

Monogram was acquired by Laboratory Corporation of America in June 2009.[2]

References

[edit]
  1. ^ SEC. "Monogram Biosciences, Inc. 2000 Quarterly Report 10-Q". SEC.report. p. 10. Retrieved 2020-06-22.
  2. ^ "LabCorp Successfully Completes Acquisition of Monogram Biosciences, Inc". Business Wire. Retrieved 28 May 2010.
[edit]
Categories